Attached files
| file | filename |
|---|---|
| EX-23.1 - CONSENT - Ocata Therapeutics, Inc. | ocata_ex2301.htm |
| EX-21.1 - SUBSIDIARIES OF THE REGISTRANT - Ocata Therapeutics, Inc. | ocata_ex2101.htm |
| EXCEL - IDEA: XBRL DOCUMENT - Ocata Therapeutics, Inc. | Financial_Report.xls |
| EX-31.1 - CERTIFICATION - Ocata Therapeutics, Inc. | ocata_ex3101.htm |
| EX-31.2 - CERTIFICATION - Ocata Therapeutics, Inc. | ocata_ex3102.htm |
| EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - Ocata Therapeutics, Inc. | ocata_ex2302.htm |
| EX-32.1 - CERTIFICATION - Ocata Therapeutics, Inc. | ocata_ex3201.htm |
| 10-K - ANNUAL REPORT - Ocata Therapeutics, Inc. | ocata_10k-123114.htm |
| EX-10.30 - 2014 STOCK OPTION AND INCENTIVE PLAN AND FORMS OF OPTION AGREEMENTS THEREUNDER - Ocata Therapeutics, Inc. | ocata_ex1030.htm |
EXHIBIT 32.2
CERTIFICATIONS OF PRINCIPAL EXECUTIVE
OFFICER
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Edward Myles, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the annual report on Form 10-K of Ocata Therapeutics, Inc. for the fiscal year ended December 31, 2014 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such report fairly presents, in all material respects, the financial condition and results of operations of Ocata Therapeutics, Inc.
| Dated: March 16, 2015 | By: | /s/ Edward Myles |
| Edward Myles | ||
| Principal Financial Officer |